Survival of lethal poxvirus infection in mice depends on TLR9, and therapeutic vaccination provides protection

J Clin Invest. 2008 May;118(5):1776-84. doi: 10.1172/JCI33940.

Abstract

Poxviruses such as the causative agent of smallpox have developed multiple strategies to suppress immune responses, including the suppression of DC activation. Since poxviruses are large DNA viruses, we hypothesized that their detection by DCs may involve the endosomal DNA recognition receptor TLR9. Indeed, we have shown here that DC recognition of ectromelia virus (ECTV), the causative agent of mousepox, completely depended on TLR9. The importance of TLR9 was highlighted by the fact that mice lacking TLR9 showed drastically increased susceptibility to infection with ECTV. In contrast, we found that the strongly attenuated poxvirus modified vaccinia virus Ankara (MVA) activated DCs by both TLR9-dependent and -independent pathways. We therefore tested whether we could use the broader induction of immune responses by MVA to protect mice from a lethal infection with ECTV. Indeed, MVA given at the same time as a lethal dose of ECTV protected mice from death. Importantly, MVA also rescued TLR9-deficient mice if administered 2 full days after an otherwise lethal infection with ECTV. Therefore, these data suggest an essential role for TLR9 in the defense against poxviruses. In addition, postexposure application of MVA may protect against lethal poxvirus infection.

MeSH terms

  • Animals
  • Dendritic Cells / cytology
  • Dendritic Cells / immunology*
  • Ectromelia virus / immunology
  • Ectromelia virus / pathogenicity
  • Humans
  • Immunity / physiology
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Poxviridae Infections* / immunology
  • Poxviridae Infections* / mortality
  • Poxviridae Infections* / prevention & control
  • Survival Rate
  • Toll-Like Receptor 9 / genetics
  • Toll-Like Receptor 9 / immunology*
  • Vaccination*
  • Vaccinia virus / immunology

Substances

  • Tlr9 protein, mouse
  • Toll-Like Receptor 9